Genecopoeia, Inc.
Rockville, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9620 Medical Center Dr #101, Rockville, MD 20850, USA
- Website
- genecopoeia.com
- Founded
- 2000
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $28,119 |
| FY2023 | $39,520 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Recombinant ALPHA1-antitrypsin therapeutics | National Institutes of Health | $107,000 | |
| Mutant miniplasmin for treatment of peripheral arterial occlusion | National Institutes of Health | $106,998 | |
| P53 fusion protein as an oncology therapeutic | National Institutes of Health | $735,508 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ampseq LLC | Gaithersburg, MD | 541380 Testing Laboratories and Services |
| Reprocell U.s.a., Inc. | Beltsville, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Creative Enzymes | Shirley, NY | 541713 Research and Development in Nanotechnology |
| Phoenix Pharmaceuticals, Inc. | Burlingame, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Quickbiology Inc. | Monrovia, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Genecopoeia, Inc. is a minority-owned, Asian-Pacific American-owned for-profit corporate entity registered in SAM.gov since 2006, specializing in biotechnology and scientific research products. The company appears to be a manufacturer of goods focused on genetic research materials, plasmid development, and biological sample services. Its current SAM.gov registration remains active through May 9, 2025, indicating ongoing eligibility to receive federal contracts and grants.
Over the past year, Genecopoeia, Inc. has secured multiple federal contract awards from civilian agencies, primarily in the biomedical research sector. The company has been awarded purchase order contracts from the National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and Veterans Integrated Service Network 7. These contracts, ranging in value from $13,349 to $22,320, have involved specialized scientific services such as providing Gateway Plus Shuttle Clone plasmids, conducting antibody autoimmune research studies, and delivering human serum samples. Each contract has been awarded as a firm fixed-price purchase order without specific set-aside designations. The contracts demonstrate Genecopoeia's capabilities in supporting federal research initiatives across different healthcare and genomic research domains, with a particular focus on detailed scientific product manufacturing and research support services.
SBA capabilities narrative
GeneCopoeia, Inc. is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.
Quick answers
Is Genecopoeia, Inc. registered in SAM.gov?
Yes. Genecopoeia, Inc.'s SAM.gov registration is active through September 17, 2027.
What is Genecopoeia, Inc.'s CAGE code?
Genecopoeia, Inc.'s CAGE code is 4DY49, and its Unique Entity ID (UEI) is CELJZYQU3MK7.
How much has Genecopoeia, Inc. received in federal contracts?
Federal contracts obligated $67,639 to Genecopoeia, Inc. in fiscal years 2023 through 2027.
What is Genecopoeia, Inc.'s most recent federal award?
Genecopoeia, Inc.'s most recent federal contract award is GC-K3038-CF gateway plus shuttle clone for STAT4(NM_001243835.2) [without stop codon] (purifi ED plasmid) (75N92E24P00271), from National Human Genome Research Institute (NIH), on August 22, 2024.
On GovTribe
See Genecopoeia, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors